B3GNT5 is a novel marker correlated with stem‐like phenotype and poor clinical outcome in human gliomas

AIMS: Glioblastoma multiforme (GBM) is the most lethal tumor with a median patient survival of 14 to 15 months. Glioma stem cells (GSCs) play a critical role in tumor initiation and therapeutic resistance in GBM. B3GNT5 has been suggested as the key glycosyltransferase in the biosynthesis of the (ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hang Yeon, Park, Seo‐Young, Kim, Hyun‐Jin, Moon, Seungju, Lee, Seongsoo, Lee, Seung Ho, Kim, Sung‐Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564194/
https://www.ncbi.nlm.nih.gov/pubmed/32677340
http://dx.doi.org/10.1111/cns.13439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564194/
https://www.ncbi.nlm.nih.gov/pubmed/32677340
http://dx.doi.org/10.1111/cns.13439

Ejemplares similares